BEXIMCO PHARMACEUTICALS LTD
Trading Code: BXPHARMA
Scrip Code: 13005

Current Market Information | ||||||||||||||||||||||||||||||
|
Contact Information and Basic Information ( As Per Last Audited Accounts) | ||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
Remarks | 1. As per letter dated 09.02.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 16,169,191 Ordinary Shares.2. As per letter dated 16.06.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 15,121,956 Ordinary Shares.3. Tk. 1,131,853,004 Revaluation Surplus has been added to Reserve and Surplus. |
Share Holding Percentage | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Financial Performance | ||||||||||
Performance Year | Basic EPS Based On | Basic EPS (restated) Based On | Net Asset Value Per Share | Restated Net Asset Value Per Share | Net Profit After Tax(mn) | % Dividend | % Dividend Yield | |||
Continuous operations | Including Extra-Ordinary Income | Continuous operations | Including Extra-Ordinary Income | Continuous operations | Including Extra-Ordinary Income | |||||
2018 | 6.25 | 0 | 0 | 0 | 66.78 | 0 | 2536.54 | 0 | 12.5%C | 1.33 |
2017 | 5.49 | 0 | 0 | 0 | 61.82 | 0 | 2226.7 | 0 | 12.5%C | 1.11 |
2016 | 2.57 | 0 | 0 | 0 | 0 | 0 | 993.77 | 0 | - | 0 |
2016 | 7.63 | 0 | 0 | 0 | 59.7 | 0 | 2948.05 | 0 | 15%C,5%B | 1.8 |
2015 | 5.06 | 0 | 0 | 0 | 58.2 | 0 | 1954.28 | 0 | - | 0 |
Financial Statements | ||
Click here to view Quarterly Financial Statement | ||
Close Price and Traded Volume Graph | ||
Click here to view 1 month graph | Click here to view 3 month graph | Click here to view 6 month graph |
©2018 Chittagong Stock Exchange Limited. All rights reserved.
Developed & Maintained by Datacraft Ltd.